Ectosense is a startup that is dedicated to empowering restful nights for individuals with sleep disorders. Leveraging advanced microelectronics, biological signal processing, and data science, the company aims to provide medical solutions to help people with sleep disorders get back to sleep. Established in 2015, Ectosense recently received a Seed Round investment on September 9, 2018 from Saffelberg Investments. With a focus on utilizing cutting-edge technology to improve the quality of sleep for those with sleep disorders, Ectosense represents an innovative player in the healthcare industry.
No recent news or press coverage available for Ectosense.